~~<i id='90963E189D'><strike id='90963E189D'><tt id='90963E189D'><pre id='90963E189D'></pre></tt></strike></i>~~

Home» comprehensive» focus

focus

author：Wikipedia 2025-09-28 09:57:19 Page View：7496

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Diabetes: Better shows data on app’s benefit with GLP-1s

Better Therapeutics announced top-line data suggesting that its prescription app for diabetes treatment, AspyreRx, can boost the impact of GLP-1 diabetes treatments. According to the release, a subgroup analysis of 160 participants in its pivotal trial on GLP-1 treatment found that the behavior modification app produced statistically significant reductions in A1C compared to a control group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alabama hospital puts IVF treatments on hold
Next article： Peter Hotez and the public health issue of online harassment

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

1:19Ademonstratorrunsonthethirdnightofprotestssparkedbythefatalpoliceshootingofa17-year-olddriverint

6 phony surgeries that take placebo to the extreme

AFP/GettyImagesMostofthetime,it’seasytobeintheplacebogroup ofaclinicaltrial:nosideeffects,minimalann

Sports medicine is finally prioritizing gender equality

MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

PBM reform efforts get punted in Congress

LawmakersinCongresshavedecidedtopunteffortstoreformhowPBMsoperate.BRENDANSMIALOWSKI/AFP/GettyImagesW